Mylan to launch EpiPen generic
Mylan N.V. (NASDAQ:MYL) said in several weeks it will launch a generic version of its EpiPen at a list price of $300 for a two-pack carton, which it said is a discount of more than 50% to the list price of branded EpiPen. The move is the latest by Mylan in the face of mounting criticism, including from a handful of U.S. Senators and Hillary Clinton, for its price increases for the epinephrine auto-injector to treat severe acute allergic reactions.
On Thursday, Mylan said it would increase the value of a savings card that reduces out-of-pocket costs for EpiPen consumers to $300 from $100, and would double eligibility for its patient assistance program to 400% of the federal poverty level. Mylan has not changed the branded EpiPen prices it charges to Medicare or private payers. ...